← Open Payments lookup

JORDAN GUSTAFSON: Open Payments

NPI 1033678644 · NEBRASKA CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$985 in 53 payments from 16 companies in 2025. Trend: 2023 $1,169 · 2024 $1,183 · 2025 $985

Food & beverage: $985
CompanyPaymentsAmount
ABBVIE INC.18$275
Lilly USA, LLC11$156
AstraZeneca Pharmaceuticals LP1$142
Sumitomo Pharma America, Inc.3$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Novartis Pharmaceuticals Corporation3$43
Abbott Laboratories2$39
Novo Nordisk Inc2$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$33
E.R. Squibb & Sons, L.L.C.2$31

Products named: VRAYLAR, BREZTRI, JARDIANCE, UBRELVY, MOUNJARO, GEMTESA, CAPLYTA, LEQVIO.

Industry payments across NE — which companies pay providers there.